Recruiting

Observational Study

Sponsor:

Adams Clinical

Code:

NCT05800925

Conditions

Major Depressive Disorder

Borderline Personality Disorder

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survey

Study Details

Brief summary:

TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.

Conditions

Major Depressive Disorder

Borderline Personality Disorder

Generalized Anxiety Disorder

Study ID

NCT05800925

Start date

Dec 21, 2021

Status verified date

May, 2026

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Dec 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
  • Participant is at least 18 years old.

Exclusion Criteria:

  • Participant is pregnant, breast-feeding, or planning to become pregnant.
  • History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
  • Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
  • Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
  • Any condition that in the investigator's opinion makes a participant unsuitable for the study.
  • Currently employed by Adams Clinical or a first-degree relative of an employee.

Study Design

Enrollment

20000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Survey

Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.

Primary outcome measure

  • The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study [ Time Frame: Up to 52 weeks ]

Central Contacts and Locations

Central contacts

Miriam Evans, PhD

617-744-8542mevans@adamsclinical.com

Locations

Adams Clinical, Boston

Recruiting

Boston, Massachusetts, United States, 02116

Contacts

Karla Meehan, MA

617-209-3469kmeehan@adamsclinical.com

Principal Investigator:

Dyanna Domilici, MD

Adams Clinical, Watertown

Recruiting

Watertown, Massachusetts, United States, 02472

Contacts

Miriam Evans, PhD

617-744-8542mevans@adamsclinical.com

Principal Investigator:

Miriam Evans, PhD

Adams Clinical, Harlem

Recruiting

New York, New York, United States, 10029

Contacts

Tessa Candiotti, LCSW

347-238-3704tcandiotti@adamsclinical.com

Principal Investigator:

Wesley Gregory, PHD

Adams Clinical, Bronx

Recruiting

The Bronx, New York, United States, 10461

Contacts

Billye Weiner, LMSW

347-218-9604bweiner@adamsclinical.com

Principal Investigator:

Shama Farooq, MD

Adams Clinical, Philadelphia

Recruiting

Philadelphia, Pennsylvania, United States, 19104

Contacts

Cassie Blanchard, PHD

617-209-3304cblanchard@adamsclinical.com

Principal Investigator:

Cassie Blanchard, PHD

Adams Clinical, Dallas

Recruiting

DeSoto, Texas, United States, 75115

Contacts

Mink Sandhu, LMSW

945-297-0835msandhu@adamsclinical.com

Principal Investigator:

Rajinder Shiwach, MD

More Information

Sponsor

Adams Clinical

Last update posted

May 20, 2026

Last verified

May, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Adams Clinical on 2026-05-20.